To order this 300+ page report, which features 140+ figuresand 125+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html
Key Market Insights
§ The microbiometherapies pipeline features 260 drugs under evaluation across different phasesof development; contract service providers have become an integral part of thesupply chain owing to their technical expertise.
§ Presently, over 25firms across the globe claim to possess the required know-how andinfrastructure to offer contract manufacturing services for live biotherapeuticproducts and microbiome therapies
§ The market isfragmented, featuring the presence of established players and mid-sized firmsacross different global regions, with capabilities to manufacture aerobic and /or anaerobic strains, at varying scales of operation
§ Most of theinstalled, global live biotherapeutic contract manufacturing capacity presentlybelongs to dedicated large and mid-sized CMOs, accounting for over 90% of whatis available across various geographies
§ Future growth of themarket is likely to be driven by increased demand for these therapeutics; weexpect the service-based revenues to grow at an annualized rate of over 46% inthe coming decade
§ In the long-term, theprojected market opportunity is anticipated to be well distributed acrossdifferent types of formulations, sizes of contract service providers andgeographical regions
For more information, please visit https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
